68727-0950
ZIIHERA
Zanidatamab-hrii
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Intravenous
ZANIDATAMAB
50.0
mg/mL
68727-0950-02
2 VIAL, SINGLE-DOSE in 1 CARTON (68727-950-02) / 6 mL in 1 VIAL, SINGLE-DOSE (68727-950-01)
Nov. 20, 2024
Immunotherapy
Bispecific Antibody
HER2
Yes
In Use